CompoAtlas

DEEP SLEEP

Natural health product licensed in Canada

Licence holder
Vitaleyoumi Wellness Inc.
NPN or DIN-HM
80129948
Status
Active licence
Licence date
5 March 2024
Revision date
Not provided
Form
Capsule, dur
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
N-Acétyl-5-méthoxytryptamine

Source : Mélatonine

1.5 mgNot calculated
5-Hydroxy-L-tryptophane15 mgNot calculated

Non-medicinal ingredients

Cellulose microcristalline, Hypromellose, Stéarate de magnésium

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years2 Capsule1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps increase the total sleep time (aspect of sleep quality) in people suffering from sleep restriction or altered sleep schedule (e.g. shift-work and jet lag). Helps to speed up/reduce the time it takes to fall asleep (sleep onset latency aspect of sleep quality) in people who fall asleep slowly/with delayed sleep phase disorder. Helps to temporarily promote relaxation.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80129948

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line